ATE367831T1 - Verfahren zur verbesserung der stabilität einer pharmazeutischen zubereitung - Google Patents

Verfahren zur verbesserung der stabilität einer pharmazeutischen zubereitung

Info

Publication number
ATE367831T1
ATE367831T1 AT01985427T AT01985427T ATE367831T1 AT E367831 T1 ATE367831 T1 AT E367831T1 AT 01985427 T AT01985427 T AT 01985427T AT 01985427 T AT01985427 T AT 01985427T AT E367831 T1 ATE367831 T1 AT E367831T1
Authority
AT
Austria
Prior art keywords
stability
improving
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
AT01985427T
Other languages
English (en)
Inventor
Andrea Fetz
Gyoergy Kis
Michel Pepiot
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170784&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE367831(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE367831T1 publication Critical patent/ATE367831T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A61L2/081—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A61L2/206—Ethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01985427T 2000-12-22 2001-12-20 Verfahren zur verbesserung der stabilität einer pharmazeutischen zubereitung ATE367831T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00128318 2000-12-22

Publications (1)

Publication Number Publication Date
ATE367831T1 true ATE367831T1 (de) 2007-08-15

Family

ID=8170784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01985427T ATE367831T1 (de) 2000-12-22 2001-12-20 Verfahren zur verbesserung der stabilität einer pharmazeutischen zubereitung

Country Status (15)

Country Link
US (4) US20040063607A1 (de)
EP (1) EP1349580B2 (de)
JP (1) JP4125957B2 (de)
CN (1) CN100396334C (de)
AR (1) AR032381A1 (de)
AT (1) ATE367831T1 (de)
BR (1) BRPI0116332B8 (de)
CA (1) CA2431906A1 (de)
CY (1) CY1106919T1 (de)
DE (1) DE60129597T3 (de)
DK (1) DK1349580T4 (de)
ES (1) ES2287173T5 (de)
PT (1) PT1349580E (de)
TW (1) TW586946B (de)
WO (1) WO2002051452A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1321144T3 (da) * 2000-09-13 2011-03-07 Santen Pharmaceutical Co Ltd Øjendråber
JP4694773B2 (ja) * 2003-06-06 2011-06-08 ロート製薬株式会社 粘膜適用液状組成物
ATE450264T1 (de) * 2003-07-31 2009-12-15 Santen Pharmaceutical Co Ltd Prostaglandin enthaltendes produkt
US20080139648A1 (en) * 2004-12-09 2008-06-12 Santen Pharmaceutical Co., Ltd. Product Containing Prostaglandin Having Fluorine Atom In Its Molecule
DK1829545T3 (da) * 2004-12-24 2012-07-23 Santen Pharmaceutical Co Ltd Produkter indeholdende prostaglandin-F2alfa-derivat
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
AU2007227091B2 (en) * 2006-03-17 2013-02-07 Johnson & Johnson Vision Care, Inc. Stabilized ophthalmic compositions comprising oxidatively unstable components
CA2664427C (en) 2006-10-04 2012-06-05 M & P Patent Aktiengesellschaft Controlled release delivery system for nasal application of neurotransmitters
EP2127638A1 (de) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom
RU2482851C2 (ru) * 2009-02-20 2013-05-27 Микро Лабс Лимитед Хранение стабильного продукта простагландина
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
EP2269575A1 (de) 2009-06-30 2011-01-05 Santen Pharmaceutical Co., Ltd Verfahren zur Verbesserung der Bioverfügbarkeit von Latanoprost
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
WO2013159057A1 (en) * 2012-04-19 2013-10-24 C. R. Bard, Inc. Infusates with enhanced ph stability under ethylene oxide sterilization
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
EP2979695B1 (de) 2013-03-29 2018-08-01 AskAt Inc. Therapeutisches mittel gegen augenerkrankungen
JP7037349B2 (ja) * 2017-06-23 2022-03-16 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
WO2018235935A1 (ja) * 2017-06-23 2018-12-27 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
KR20200035047A (ko) * 2017-08-03 2020-04-01 산텐 세이야꾸 가부시키가이샤 클로르헥시딘을 함유하는 의약 조성물
MX388336B (es) * 2019-09-06 2025-03-19 Sophia Holdings S A De C V Composicion farmacéutica oftálmica, procesos de preparación y usos de las mismas
JPWO2022014707A1 (de) 2020-07-16 2022-01-20
PE20241644A1 (es) * 2021-03-16 2024-08-09 Vyluma Inc Envase multi-dosis para composiciones oftalmica
US12233049B2 (en) 2021-11-15 2025-02-25 Slayback Pharma Llc Stable pharmaceutical compositions of clonidine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE523577A (de) * 1952-10-16
GB1107600A (en) † 1965-12-15 1968-03-27 U M P Venesta Ltd Improvements relating to collapsible tubular containers
CH483963A (fr) * 1968-01-11 1970-01-15 U M P Venesta Ltd Récipient tubulaire souple
NL7009539A (de) * 1969-07-07 1971-01-11
US3728839A (en) * 1971-04-29 1973-04-24 American Cyanamid Co Storage stable surgically absorbable polyglycolic acid products
US4482585A (en) * 1982-06-11 1984-11-13 Toppan Printing Co., Ltd. Container resistant to extremely low temperatures
US5382406A (en) * 1990-04-17 1995-01-17 Abbott Laboratories Sterile filling method
JP3256997B2 (ja) † 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤
US5620425A (en) * 1993-11-03 1997-04-15 Bracco International B.V. Method for the preparation of pre-filled plastic syringes
US5749203A (en) * 1994-09-23 1998-05-12 Kimberly-Clark Corporation Method of packaging a medical article
SE515221C2 (sv) * 1996-03-20 2001-07-02 Scandimed Internat Ab Förfarande för framställning av och anordning vid en förpackning med en sterilt förpackad behållare med sterilt innehåll
US6132679A (en) * 1997-12-24 2000-10-17 Alliedsignal, Inc. Method and apparatus for aerating chemically-sterilized articles
WO2000033895A1 (en) * 1998-12-07 2000-06-15 Baylor College Of Medicine Preventing and removing biofilm from the surface of medical devices
US6440364B1 (en) * 1999-02-16 2002-08-27 Ethicon, Inc. Method of degassing absorbable suture products
US6231810B1 (en) * 1999-04-21 2001-05-15 Stryker Technologies Corporation Special cycle for ethylene oxide sterilization
EP1352837B1 (de) * 1999-05-28 2006-02-22 Novartis AG Herstellungsverfahren einer sterilisierten Quetschverpackung für ein pharmazeutisches Produkt

Also Published As

Publication number Publication date
CY1106919T1 (el) 2012-09-26
EP1349580B2 (de) 2012-07-04
US20080300277A1 (en) 2008-12-04
DE60129597T2 (de) 2008-04-17
PT1349580E (pt) 2007-10-25
DE60129597T3 (de) 2012-11-29
ES2287173T3 (es) 2007-12-16
WO2002051452A1 (en) 2002-07-04
JP4125957B2 (ja) 2008-07-30
CA2431906A1 (en) 2002-07-04
DK1349580T4 (da) 2012-10-08
US20040063607A1 (en) 2004-04-01
TW586946B (en) 2004-05-11
EP1349580A1 (de) 2003-10-08
DE60129597D1 (de) 2007-09-06
BR0116332A (pt) 2004-03-02
CN100396334C (zh) 2008-06-25
JP2004516099A (ja) 2004-06-03
CN1481259A (zh) 2004-03-10
DK1349580T3 (da) 2007-10-01
EP1349580B1 (de) 2007-07-25
BRPI0116332B8 (pt) 2021-06-22
ES2287173T5 (es) 2012-10-03
US20110173928A1 (en) 2011-07-21
BR0116332B1 (pt) 2014-08-19
US20130097969A1 (en) 2013-04-25
AR032381A1 (es) 2003-11-05

Similar Documents

Publication Publication Date Title
ATE367831T1 (de) Verfahren zur verbesserung der stabilität einer pharmazeutischen zubereitung
DE60119283D1 (de) Verfahren zur herstellung von 3-hydroxypicolinsäure-derivaten
DE122007000077I1 (de) Verfahren zur Herstellung von substituierten Octanoyl-Amiden
DE60210718D1 (de) Verfahren zur Herstellung einer Reparaturlackierung
DE60125747D1 (de) Verfahren zur herstellung von 2-halobenzoesäuren
DE10080605T1 (de) Verfahren zur Herstellung von Bisphenol A
DE60117106D1 (de) Verfahren zur Herstellung von Halopropyldimethylchlorosilanen
DE60124833D1 (de) Verfahren zur Herstellung eines Heissschmelzklebers
DE60109545D1 (de) Verfahren zur Herstellung einer Aromazusammensetzung auf Pilzbasis
DE60236171D1 (de) Verfahren for zur herstellung eines 14-hydroxynormorphinon-derivats
ATE266950T1 (de) Verfahren zur verbesserung der füllfähigkeit von tabak
DE60026607T8 (de) Verfahren zur Herstellung von Perfluoralkadienen
DE60116874D1 (de) Verfahren zur herstellung von (r)-2-alkyl-3-phenyl-1-propanolen
DE60108668D1 (de) Verfahren zur herstellung von phenethylamin-derivaten
DE60033877D1 (de) Verfahren zur Herstellung von Dimethylsulfoxid
DE60043261D1 (de) Verfahren zur herstellung von phenylessigsäure derivaten
DE60233589D1 (de) Verfahren zur herstellung von echinocandinderivaten
DE50005403D1 (de) Verfahren zur Herstellung von Monoisopropylamin
DE60104691D1 (de) Verfahren zur herstellung von pyrazolopyrimidinonen
DE60102763D1 (de) Verfahren zur Herstellung von Dihydroperimidin-Squarainverbindungen
DE50006651D1 (de) Verfahren zur Splice-Vorbereitung
DE60110807D1 (de) Kontinuierliches verfahren zur herstellung von pestiziden chlorthiazolen
DE60114098D1 (de) Ein verfahren zur herstellung von trifluorothymidin-derivaten
ATE300198T1 (de) Verfahren zur verbesserung der füllfähigkeit von tabak
DE50013395D1 (de) Verfahren zur Herstellung von ÄIrCODClÜ2

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1349580

Country of ref document: EP